(Reuters) - Eli Lilly on Monday again extended its deadline for Point Biopharma Global shareholders to sell their shares to the drugmaker, following low participation amid investor concerns that the offer price was low. Lilly set Dec. 15 as the deadline in a third...
Category
Business
GM’s Cruise may face fines for ‘misleading’ regulator over accident
By Joseph White, Hyunjoo Jin and David Shepardson (Reuters) -General Motors' Cruise robotaxi unit could face $1.5 million in fines and additional sanctions over its failure to disclose details of an Oct. 2 accident in which a robotaxi dragged a pedestrian 20 feet (6.1...
Wall Street ends down as megacaps give back gains
By Noel Randewich and Shristi Achar A (Reuters) - U.S. stocks ended lower on Monday, interrupting last week's rally, as investors turned cautious ahead of employment data due this week that could alter expectations that the Federal Reserve will cut interest rates...